← All trials
NCT03474029
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2018
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 3400
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Medical Research CouncilCollaborator
- University of LondonStudy chair
- Centers for Disease Control and Prevention (CDC)Study director
- Government of ColoradoStudy chair
- Vanderbilt UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.